{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:43:11Z","timestamp":1791283391912,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijrobp.2023.07.018","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T05:21:32Z","timestamp":1690435292000},"page":"94-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of Sarcopenia With Toxicity-Related Discontinuation of Adjuvant Endocrine Therapy in Women With Early-Stage Hormone Receptor\u2013Positive Breast Cancer"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8199-2782","authenticated-orcid":false,"given":"Anurag","family":"Saraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Sophia W.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Erik","family":"Tonnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle","family":"Tillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Roeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Nipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Comander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Peppercorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian J.","family":"Fintelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel B.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.07.018_bib0001","doi-asserted-by":"crossref","first-page":"djv048","DOI":"10.1093\/jnci\/djv048","article-title":"Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race\/ethnicity, poverty, and state","volume":"107","author":"Kohler","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0002","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0003","first-page":"405","article-title":"Endocrine therapy for early breast cancer: Updated review","volume":"17","author":"Tremont","year":"2017","journal-title":"Ochsner J"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0004","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0005","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0006","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0007","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/bjc.2013.116","article-title":"Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality","volume":"108","author":"Makubate","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0008","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2015.63.8619","article-title":"Treatment adherence and its impact on disease-free survival in the Breast International Group 1-98 Trial of tamoxifen and letrozole, alone and in sequence","volume":"34","author":"Chirgwin","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0009","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jgo.2018.11.008","article-title":"Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer","volume":"10","author":"Sitlinger","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0010","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(08)70259-6","article-title":"Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: A retrospective analysis of the ATAC trial","volume":"9","author":"Cuzick","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0011","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1002\/cncr.24508","article-title":"Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: A Danish population-based cohort study","volume":"115","author":"Hernandez","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0012","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1200\/JCO.2007.14.0921","article-title":"Impact of raloxifene or tamoxifen use on endometrial cancer risk: A population-based case-control study","volume":"26","author":"DeMichele","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0013","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0014","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1470-2045(08)70182-7","article-title":"Risk factors for joint symptoms in patients enrolled in the ATAC trial: A retrospective, exploratory analysis","volume":"9","author":"Sestak","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0015","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","article-title":"Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer","volume":"25","author":"Crew","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0016","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/annonc\/mdr448","article-title":"Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21\/07)","volume":"23","author":"Zaman","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0017","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus Tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0018","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): A randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0019","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.2011.38.0261","article-title":"Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer","volume":"30","author":"Henry","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0020","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1200\/JCO.21.00102","article-title":"Sarcopenia in the older adult with cancer","volume":"39","author":"Williams","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0021","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0022","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0024","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","article-title":"Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0025","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0026","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","article-title":"Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer","volume":"34","author":"Blauwhoff-Buskermolen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0027","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1038\/s41598-022-17451-1","article-title":"Effects of sarcopenia and sarcopenic obesity on joint pain and degenerative osteoarthritis in postmenopausal women","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0028","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jcsm.12908","article-title":"Prevalence of depression in patients with sarcopenia and correlation between the two diseases: Systematic review and meta-analysis","volume":"13","author":"Li","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0029","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0030","first-page":"861","article-title":"Impact of body composition on outcome in patients with early breast cancer","volume":"26","author":"Deluche","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0031","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10549-018-4915-7","article-title":"Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer","volume":"172","author":"Song","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0032","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.210080","article-title":"A fully automated deep learning pipeline for multi-vertebral level quantification and characterization of muscle and adipose tissue on chest CT scans","volume":"4","author":"Bridge","year":"2022","journal-title":"Radiol Artif Intell"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0033","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2214\/AJR.22.27484","article-title":"Utility of noncancerous chest CT features for predicting overall survival and noncancer death in patients with stage I lung cancer treated with stereotactic body radiotherapy","volume":"219","author":"Tahir","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0034","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1158\/1078-0432.CCR-16-2266","article-title":"Body composition as a predictor of toxicity in patients receiving anthracycline and taxane-based chemotherapy for early-stage breast cancer","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0035","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1038\/s41598-018-29825-5","article-title":"Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population","volume":"8","author":"Derstine","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0036","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jcsm.12848","article-title":"Percentile-based averaging and skeletal muscle gauge improve body composition analysis: Validation at multiple vertebral levels","volume":"13","author":"Marquardt","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0037","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1634\/theoncologist.2011-0037","article-title":"Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: A TEAM study analysis","volume":"17","author":"van de Water","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0038","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","article-title":"Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: A systematic review","volume":"134","author":"Murphy","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0039","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10549-022-06583-7","article-title":"Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer","volume":"193","author":"Lemij","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0040","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1158\/1078-0432.CCR-20-3974","article-title":"Early discontinuation of endocrine therapy and recurrence of breast cancer among premenopausal women","volume":"27","author":"Collin","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0041","doi-asserted-by":"crossref","unstructured":"Prado CMM, Lima ISF, Baracos VE, et al. An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity. Cancer Chemother Pharmacol. 20211;67:93-101.","DOI":"10.1007\/s00280-010-1288-y"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0042","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3390\/cancers13081806","article-title":"Association between skeletal muscle loss and the response to neoadjuvant chemotherapy for breast cancer","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0043","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10549-022-06741-x","article-title":"Association of sarcopenia with endocrine therapy toxicity in patients with early breast cancer","volume":"196","author":"Aleixo","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0044","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01635581.2019.1659381","article-title":"Measurement of muscle mass and sarcopenia using anthropometry, bioelectrical impedance, and computed tomography in surgical patients with colorectal malignancy: Comparison of agreement between methods","volume":"72","author":"Jones","year":"2020","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/jcm8030322","article-title":"Predictors of discordance in the assessment of skeletal muscle mass between computed tomography and bioimpedance analysis","volume":"8","author":"Jo","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0046","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.breast.2021.05.004","article-title":"Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study","volume":"58","author":"Ormel","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0047","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): A randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0048","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: A randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0049","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-conserving surgery with or without irradiation in early breast cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0050","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10549-009-0724-3","article-title":"Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: A population-based analysis","volume":"122","author":"van Herk-Sukel","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0051","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2003.07.071","article-title":"Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer","volume":"21","author":"Partridge","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.07.018_bib0052","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/jamaoncol.2021.1693","article-title":"Association of modifiable risk factors with early discontinuation of adjuvant endocrine therapy: A post hoc analysis of a randomized clinical trial","volume":"7","author":"Yanez","year":"2021","journal-title":"JAMA Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623076794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623076794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:10:53Z","timestamp":1759745453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623076794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0360301623076794"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.018","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Sarcopenia With Toxicity-Related Discontinuation of Adjuvant Endocrine Therapy in Women With Early-Stage Hormone Receptor\u2013Positive Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}